RMD vs. SOLV: ResMed vs. Solventum Stock Comparison
How do ResMed (RMD) and Solventum (SOLV) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.
Company Profile
ResMed (RMD) and Solventum (SOLV) both belong to the Health Care Equipment & Supplies industry, though RMD is classified under Health Care Equipment while SOLV falls under Health Care Supplies.
ResMed (RMD) carries decades of public-market history since June 2, 1995, while Solventum (SOLV) listed on March 26, 2024 — long-window comparisons have far more historical data on the RMD side.
| Profile Item | RMD | SOLV |
|---|---|---|
| Name | ResMed Inc. | Solventum Corporation |
| Country/Region | United States | United States |
| GICS Sector | Health Care | Health Care |
| GICS Industry Group | Health Care Equipment & Services | Health Care Equipment & Services |
| GICS Industry | Health Care Equipment & Supplies | Health Care Equipment & Supplies |
| GICS Sub-Industry | Health Care Equipment | Health Care Supplies |
| Market Capitalization | 33.10 billion USD | 15.36 billion USD |
| Currency | USD | USD |
| Exchange | NYSE | NYSE |
| Listing Date | June 2, 1995 | March 26, 2024 |
| Security Type | Common Stock | Common Stock |
Price Performance
Cumulative Growth
Trailing Returns
Calendar-Year Returns
Performance Metrics
| Metric | RMD | SOLV |
|---|---|---|
| Total Return (1Y) | -5.42% | 25.89% |
| Total Return (3Y, Annualized) | 18.99% | -- |
| Total Return (5Y, Annualized) | -1.23% | -- |
Risk Profile
Drawdown History
Return Distribution
Risk Metrics
| Metric | RMD | SOLV |
|---|---|---|
| Volatility (1Y, Annualized) | 30.80% | 30.06% |
| Beta (5Y) | 0.75 | 0.62 |
| Max Drawdown (5Y) | -49.04% | -39.98% |
| Avg. Volume (3M) | 1.32M | 1.05M |
Risk-Adjusted Performance
Risk-Return Positioning
Risk-Adjusted Metrics
| Metric | RMD | SOLV |
|---|---|---|
| Sharpe Ratio (1Y) | -0.31 | 0.72 |
| Sortino Ratio (1Y) | -0.43 | 1.08 |
Profitability
ROE (TTM)
ResMed (RMD) at 26.40% sits in the top ROE quartile, while Solventum (SOLV) at 3.19% is closer to the peer norm — stronger capital efficiency for RMD.
RMD
Health Care Equipment & Services industry group
26.40%
- Max
- 47.61%
- RMD
- 26.40%
- Q3
- 14.36%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
SOLV
Health Care Equipment & Services industry group
3.19%
- Max
- 47.61%
- Q3
- 14.36%
- Median
- 5.45%
- SOLV
- 3.19%
- Q1
- -10.67%
- Min
- -47.01%
Net Margin (TTM)
ResMed (RMD) at 27.79% retains a top-quartile share of revenue as profit, ahead of Solventum (SOLV) at 1.91%, which keeps about the industry-typical share.
RMD
Health Care Equipment & Services industry group
27.79%
- Max
- 29.35%
- RMD
- 27.79%
- Q3
- 9.33%
- Median
- 2.18%
- Q1
- -6.29%
- Min
- -28.46%
SOLV
Health Care Equipment & Services industry group
1.91%
- Max
- 29.35%
- Q3
- 9.33%
- Median
- 2.18%
- SOLV
- 1.91%
- Q1
- -6.29%
- Min
- -28.46%
Operating Margin (TTM)
ResMed (RMD) at 34.82% operates in the top operating margin quartile, ahead of Solventum (SOLV) at 6.82%, which runs around its industry’s norm.
RMD
Health Care Equipment & Services industry group
34.82%
- Max
- 35.43%
- RMD
- 34.82%
- Q3
- 14.14%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
SOLV
Health Care Equipment & Services industry group
6.82%
- Max
- 35.43%
- Q3
- 14.14%
- SOLV
- 6.82%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
Profitability Metrics
| Metric | RMD | SOLV |
|---|---|---|
| ROE (TTM) | 26.40% | 3.19% |
| ROA (TTM) | 14.76% | 2.29% |
| Net Margin (TTM) | 27.79% | 1.91% |
| Operating Margin (TTM) | 34.82% | 6.82% |
| Gross Margin (TTM) | 61.77% | 55.13% |
Growth
Revenue Growth
ResMed (RMD) at 9.85% is around its peer norm for revenue growth, while Solventum (SOLV) at 0.86% drops into the bottom quartile, signaling weaker demand or pricing momentum.
EPS Growth
Only one side can be read here: Solventum (SOLV) reports EPS growth of 221.74%, ranked against its industry; ResMed (RMD) has no EPS growth figure this period.
Growth Metrics
| Metric | RMD | SOLV |
|---|---|---|
| Revenue Growth (YoY) | 9.85% | 0.86% |
| Revenue Growth (3Y CAGR) | 10.21% | 0.79% |
| EPS Growth (YoY) | -- | 221.74% |
| EPS Growth (3Y CAGR) | 19.64% | 4.51% |
Financial Strength
Current Ratio (MRQ)
ResMed (RMD) at 2.65 keeps current ratio within its industry’s typical mid-range, while Solventum (SOLV) at 1.03 runs in the tighter-liquidity quartile — a thinner cushion against current liabilities for SOLV.
RMD
Health Care Equipment & Services industry group
2.65
- Max
- 7.59
- Q3
- 4.00
- RMD
- 2.65
- Median
- 1.98
- Q1
- 1.37
- Min
- 0.30
SOLV
Health Care Equipment & Services industry group
1.03
- Max
- 7.59
- Q3
- 4.00
- Median
- 1.98
- Q1
- 1.37
- SOLV
- 1.03
- Min
- 0.30
Debt / Equity (MRQ)
ResMed (RMD) at 0.10 keeps leverage in the lower quartile, while Solventum (SOLV) at 1.10 sits in the higher-leverage quartile.
RMD
Health Care Equipment & Services industry group
0.10
- Max
- 1.88
- Q3
- 0.91
- Median
- 0.58
- Q1
- 0.16
- RMD
- 0.10
- Min
- 0.00
SOLV
Health Care Equipment & Services industry group
1.10
- Max
- 1.88
- SOLV
- 1.10
- Q3
- 0.91
- Median
- 0.58
- Q1
- 0.16
- Min
- 0.00
Financial Strength Metrics
| Metric | RMD | SOLV |
|---|---|---|
| Current Ratio (MRQ) | 2.65 | 1.03 |
| Debt / Equity (MRQ) | 0.10 | 1.10 |
| Net Debt / EBITDA | -0.19 | 4.66 |
Dividends
Dividend Yield (TTM)
Solventum (SOLV) pays no dividend (yield 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile ResMed (RMD) reports a yield of 1.03%, ranking against industry peers normally.
RMD
Health Care Equipment & Services industry group
1.03%
- RMD
- 1.03%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
SOLV
Health Care Equipment & Services industry group
0.00%
- SOLV
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Payout Ratio (TTM)
Solventum (SOLV) pays no dividend (payout 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile ResMed (RMD) reports a payout of 22.40%, ranking against industry peers normally.
RMD
Health Care Equipment & Services industry group
22.40%
- RMD
- 22.40%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
SOLV
Health Care Equipment & Services industry group
0.00%
- SOLV
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Metrics
| Metric | RMD | SOLV |
|---|---|---|
| Dividend Yield (TTM) | 1.03% | 0.00% |
| Dividend Payout Ratio (TTM) | 22.40% | 0.00% |
Valuation
P/E Ratio (TTM)
ResMed (RMD) at 21.43 is near its industry’s usual P/E ratio, while Solventum (SOLV) at 101.55 sits above its peer range — an unusually expensive price for SOLV’s trailing earnings.
RMD
Health Care Equipment & Services industry group
21.43
- Max
- 80.41
- Q3
- 47.62
- Median
- 29.93
- RMD
- 21.43
- Q1
- 21.19
- Min
- 4.21
SOLV
Health Care Equipment & Services industry group
101.55
- SOLV
- 101.55
- Max
- 80.41
- Q3
- 47.62
- Median
- 29.93
- Q1
- 21.19
- Min
- 4.21
P/S Ratio (TTM)
Solventum (SOLV) at 1.88 is priced about in line with its industry on P/S ratio, while ResMed (RMD) at 5.77 sits in the pricier quartile — RMD costs more per dollar of sales.
RMD
Health Care Equipment & Services industry group
5.77
- Max
- 8.80
- RMD
- 5.77
- Q3
- 4.32
- Median
- 2.13
- Q1
- 1.10
- Min
- 0.03
SOLV
Health Care Equipment & Services industry group
1.88
- Max
- 8.80
- Q3
- 4.32
- Median
- 2.13
- SOLV
- 1.88
- Q1
- 1.10
- Min
- 0.03
P/B Ratio (MRQ)
On P/B ratio, both ResMed (RMD) at 5.56 and Solventum (SOLV) at 3.20 are valued close to their industries’ norm against book — neither stands out from peers.
RMD
Health Care Equipment & Services industry group
5.56
- Max
- 11.68
- Q3
- 6.12
- RMD
- 5.56
- Median
- 3.00
- Q1
- 1.73
- Min
- -1.31
SOLV
Health Care Equipment & Services industry group
3.20
- Max
- 11.68
- Q3
- 6.12
- SOLV
- 3.20
- Median
- 3.00
- Q1
- 1.73
- Min
- -1.31
Valuation Metrics
| Metric | RMD | SOLV |
|---|---|---|
| P/E Ratio (TTM) | 21.43 | 101.55 |
| P/S Ratio (TTM) | 5.77 | 1.88 |
| P/B Ratio (MRQ) | 5.56 | 3.20 |
| Free Cash Flow Yield (TTM) | 3.92% | 1.31% |